Association between Cardiovascular Health, C-Reactive Protein, and Comorbidities in Spanish Urban-Dwelling

Ana María Armas-Padrón1, Miriam Sicilia-Sosvilla1, Pedro Ruiz-Esteban2

  • 1La Cuesta Primary Healthcare Centre, Universidad de la Laguna, La Laguna, E-38320 Tenerife, Spain.

Insights

Maintaining ideal cardiovascular health metrics is crucial for overweight and obese hypertensive patients. Improving these metrics can reduce low-grade inflammation and prevent organ damage and comorbidities.

Area of Science:

  • Cardiology
  • Public Health
  • Inflammation Research

Background:

  • Hypertension-mediated organ damage (HMOD) and comorbidities (HRC) are significant concerns in overweight/obese (Ow/Ob) hypertensive patients.
  • The interplay between cardiovascular health metrics (CVHM), low-grade inflammation (LGI), and HMOD-HRC in this population is not well understood.

Purpose of the Study:

  • To investigate the association between CVHM score, LGI, and HMOD-HRC in hypertensive patients with an Ow/Ob phenotype.
  • To determine the relationship between body mass index (BMI), hs-C-reactive protein (CRP) levels, and HMOD-HRC.

Main Methods:

  • Cross-sectional study of 243 hypertensive patients from an urban primary care center.
  • Collected baseline CVHM scores, BMI, hs-CRP levels, and data on prevalent/incident HMOD-HRC and mortality.
  • Utilized linear regression and multivariate binary logistic regression analyses.

Main Results:

  • Higher BMI correlated significantly with higher hs-CRP levels.
  • Lower ideal CVHM scores were associated with increased risk of HMOD-HRC.
  • Elevated hs-CRP levels were linked to HMOD-HRC in the overall cohort and Ow/Ob subpopulations.

Conclusions:

  • Ideal CVHM are critical for mitigating LGI and preventing HMOD-HRC in hypertensive individuals with an Ow/Ob phenotype.
  • Early interventions targeting improved CVHM are necessary to reduce cardiovascular disease risk in this population.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
119
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
21
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
53
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
27
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
24
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
16